These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19800466)

  • 21. Role of pre-surgical breast MRI in the management of invasive breast carcinoma.
    Del Frate C; Borghese L; Cedolini C; Bestagno A; Puglisi F; Isola M; Soldano F; Bazzocchi M
    Breast; 2007 Oct; 16(5):469-81. PubMed ID: 17433681
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The accurate staging of ovarian cancer using 3T magnetic resonance imaging--a realistic option.
    Booth SJ; Turnbull LW; Poole DR; Richmond I
    BJOG; 2008 Jun; 115(7):894-901. PubMed ID: 18485169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer?
    Houssami N; Hayes DF
    CA Cancer J Clin; 2009; 59(5):290-302. PubMed ID: 19679690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of margin status in lumpectomy specimens and residual breast carcinoma.
    Scopa CD; Aroukatos P; Tsamandas AC; Aletra C
    Breast J; 2006; 12(2):150-3. PubMed ID: 16509840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast magnetic resonance imaging for preoperative locoregional staging.
    Hollingsworth AB; Stough RG; O'Dell CA; Brekke CE
    Am J Surg; 2008 Sep; 196(3):389-97. PubMed ID: 18436185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancer.
    Voguet L; Hébert T; Levêque J; Acker O; Mesbah H; Marret H; Porée P; Body G
    Breast; 2009 Aug; 18(4):233-7. PubMed ID: 19628389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is there a role for routine use of MRI in selection of patients for breast-conserving cancer therapy?
    Grobmyer SR; Mortellaro VE; Marshall J; Higgs GM; Hochwald SN; Mendenhall NP; Copeland EM; Cance WG
    J Am Coll Surg; 2008 May; 206(5):1045-50; discussion 1050-2. PubMed ID: 18471753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of resection margins in patients treated with breast conservation surgery.
    Zavagno G; Goldin E; Mencarelli R; Capitanio G; Del Bianco P; Marconato R; Mocellin S; Marconato G; Belardinelli V; Marcon F; Nitti D
    Cancer; 2008 May; 112(9):1923-31. PubMed ID: 18327818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for recurrences in patients treated with breast-conserving surgery: is there a role for MRI?
    Gorechlad JW; McCabe EB; Higgins JH; Likosky DS; Lewis PJ; Rosenkranz KM; Barth RJ
    Ann Surg Oncol; 2008 Jun; 15(6):1703-9. PubMed ID: 18266039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of imprint cytology for assessment of surgical margins in lumpectomy specimens of breast cancer patients.
    Bakhshandeh M; Tutuncuoglu SO; Fischer G; Masood S
    Diagn Cytopathol; 2007 Oct; 35(10):656-9. PubMed ID: 17854083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Scientific Presentation Award: The impact of magnetic resonance imaging on surgical treatment of invasive breast cancer.
    Carpenter SG; Stucky CC; Dueck AC; Grimsby G; Giurescu M; Apsey H; Gray RJ; Pockaj BA
    Am J Surg; 2009 Oct; 198(4):475-81. PubMed ID: 19800451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast magnetic resonance imaging characteristics in women with occult primary breast carcinoma.
    Lieberman S; Sella T; Maly B; Sosna J; Uziely B; Sklair-Levy M
    Isr Med Assoc J; 2008 Jun; 10(6):448-52. PubMed ID: 18669145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of preoperative MRI on breast-conserving surgery of invasive cancer: a comparative cohort study.
    Pengel KE; Loo CE; Teertstra HJ; Muller SH; Wesseling J; Peterse JL; Bartelink H; Rutgers EJ; Gilhuijs KG
    Breast Cancer Res Treat; 2009 Jul; 116(1):161-9. PubMed ID: 18807269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of residual disease using breast MRI after excisional biopsy for breast cancer.
    Chae EY; Cha JH; Kim HH; Shin HJ; Kim H; Lee J; Cheung JY
    AJR Am J Roentgenol; 2013 May; 200(5):1167-73. PubMed ID: 23617506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Residual disease after re-excision for tumour-positive surgical margins in both ductal carcinoma in situ and invasive carcinoma of the breast: The effect of time.
    Schouten van der Velden AP; Van de Vrande SL; Boetes C; Bult P; Wobbes T
    J Surg Oncol; 2007 Dec; 96(7):569-74. PubMed ID: 17680635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy.
    Rosen EL; Blackwell KL; Baker JA; Soo MS; Bentley RC; Yu D; Samulski TV; Dewhirst MW
    AJR Am J Roentgenol; 2003 Nov; 181(5):1275-82. PubMed ID: 14573420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRI versus ultrasonography and mammography for preoperative assessment of breast cancer.
    Wasif N; Garreau J; Terando A; Kirsch D; Mund DF; Giuliano AE
    Am Surg; 2009 Oct; 75(10):970-5. PubMed ID: 19886147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasound.
    Pediconi F; Catalano C; Roselli A; Dominelli V; Cagioli S; Karatasiou A; Pronio A; Kirchin MA; Passariello R
    Invest Radiol; 2009 Jul; 44(7):412-21. PubMed ID: 19448554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The value of magnetic resonance imaging in the diagnosis of residual or recurrent acquired cholesteatoma after canal wall-up tympanoplasty.
    Jeunen G; Desloovere C; Hermans R; Vandecaveye V
    Otol Neurotol; 2008 Jan; 29(1):16-8. PubMed ID: 18199952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation of targeted ultrasound with magnetic resonance imaging abnormalities of the breast.
    Beran L; Liang W; Nims T; Paquelet J; Sickle-Santanello B
    Am J Surg; 2005 Oct; 190(4):592-4. PubMed ID: 16164928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.